Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease (Q40912121)

24 September 2017

title

Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease (English)

1 reference

24 September 2017

0 references

1 reference

8

Drexler HG

1 reference

24 September 2017

Knecht H

1

1 reference

24 September 2017

Berger C

2

1 reference

24 September 2017

McQuain C

3

1 reference

24 September 2017

Rothenberger S

4

1 reference

24 September 2017

Bachmann E

5

1 reference

24 September 2017

Martin J

6

1 reference

24 September 2017

Esslinger C

7

1 reference

24 September 2017

Cai YC

9

1 reference

24 September 2017

Quesenberry PJ

10

1 reference

24 September 2017

Odermatt BF

11

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

24 September 2017

1 reference

24 September 2017

volume

18

1 reference

24 September 2017

issue

50

1 reference

24 September 2017

page(s)

7161-7167

1 reference

Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

TRAF6 is a signal transducer for interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

A cytoplasmic inhibitor of the JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Establishment of a malignant, epstein-barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Inhibition of TNF-induced apoptosis by NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

7 January 2021

Pathology of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

7 January 2021

Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

7 January 2021

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

7 January 2021

Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203177

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203177

1 reference

Dimensions Publication ID

24 September 2017

1025818313

0 references

1 reference